(Q50621981)

English

Outcomes and predicting response in anaemic chemotherapy patients treated with epoetin alfa. A multicentre, 4-month, open-label study in Australia and New Zealand.

scientific article published in October 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/19143877

Outcomes and predicting response in anaemic chemotherapy patients treated with epoetin alfa. A multicentre, 4-month, open-label study in Australia and New Zealand. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/19143877

0 references

0 references

3

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/19143877

author name string

D Bell

1

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/19143877

D Grimes

2

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/19143877

D Dalley

4

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/19143877

T Blackwell

5

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/19143877

R Fox

6

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/19143877

M Jeffery

7

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/19143877

publication date

1 October 2008

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/19143877

Internal Medicine Journal

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/19143877

38

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/19143877

10

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/19143877

751-757

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/19143877

Recombinant human erythropoietin in oncology: current status and further developments

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01736.X

21 January 2018

Epoetin in cancer-related anaemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01736.X

21 January 2018

Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01736.X

21 January 2018

Predicting the hematopoietic response to recombinant human erythropoietin (Epoetin alfa) in the treatment of the anemia of cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01736.X

21 January 2018

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01736.X

21 January 2018

Cancer-related anemia and recombinant human erythropoietin--an updated overview

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01736.X

21 January 2018

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01736.X

21 January 2018

Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01736.X

21 January 2018

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01736.X

21 January 2018

Epoetin alfa improves quality of life in patients with cancer: results of metaanalysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01736.X

21 January 2018

Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.2008.01736.X

21 January 2018

Identifiers

10.1111/J.1445-5994.2008.01736.X

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/19143877

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 March 2018

http://europepmc.org/abstract/MED/19143877

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50621981&oldid=951346388"